US2025113855A1PendingUtilityA1
Hydrating and rehydrating compositoin and product
Assignee: IV THOUGHT PRODUCTS AND DESIGN CORPPriority: Sep 20, 2023Filed: Sep 19, 2024Published: Apr 10, 2025
Est. expirySep 20, 2043(~17.1 yrs left)· nominal 20-yr term from priority
Inventors:Samuel L. Morris, Iii
B65D 81/22A24B 15/167
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A rehydrating cannabis solution contains a modified cannabis hash oil. The modified cannabis hash oil is derived from a cannabis hash oil extracted from a marijuana plant and the cannabis hash oil has cannabis chemical compounds and over 10% of the cannabis chemical compounds are cannabinoid compounds. The modified cannabis hash oil has the cannabis chemical compounds and the percentage of cannabinoid compounds ranges between 0.01% and up to 0.3%.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A rehydrating cannabis solution comprising
a modified cannabis hash oil
(a) derived from a cannabis hash oil extracted from a marijuana plant and the cannabis hash oil has (i) cannabis chemical compounds and (ii) over 10% of the cannabis chemical compounds are cannabinoid compounds;
(b) has the cannabis chemical compounds and
(c) has a percentage of cannabinoid compounds that ranges between 0.01% and up to 0.3%.
2 . The rehydrating cannabis solution of claim 1 wherein modified cannabis hash oil has the percentage of cannabinoid compounds ranging between 0.1% and up to 0.3% by extracting the cannabinoid compounds from the cannabis hash oil; the extracted cannabinoid compounds are selected from the group consisting of at least one of the following tetrahydrocannabinol compounds:
(−)-Δ 9 -trans-tetrahydrocannabinol; (−)-Δ 9 -trans-tetrahydrocannabinolic acid A; (−)-Δ 9 -trans-tetrahydrocannabinolic acid B; (−)-Δ 9 -trans-tetrahydrocannabiorcol; (−)-Δ 9 -trans-tetrahydrocannabinal; (−)-Δ 9 -trans-tetrahydrocannabivarinic acid; (−)-Δ 9 -trans-tetrahydrocannabinol-C 4 ; (−)-Δ 9 -trans-tetrahydrocannabinolic acid A-C 4 ; (−)-Δ 9 -trans-tetrahydrocannabivarin; β-fenchyl (−)-d-9-trans-tetrahydrocannabinolate; (−)-Δ 9 -trans-tetrahydrocannabiorcolic acid; α-fenchyl (−)-Δ 9 -trans-tetrahydrocannabinolate; epi-bornyl (−)-Δ 9 -trans-tetrahydrocannabinolate; bornyl (−)-Δ 9 -trans-tetrahydrocannabinolate; α-terpenyl (−)-Δ 9 -trans-tetrahydrocannabinolate; 4-terpenyl (−)-Δ 9 -trans-tetrahydrocannabinolate; α-cadinyl (−)-Δ 9 -trans-tetrahydrocannabinolate; γ-eudesmyl (−)-Δ 9 -trans-tetrahydrocannabinolate; 8α-hydroxy-(−)-Δ 9 -trans-tetrahydrocannabinol; 8β-hydroxy-(−)-Δ 9 -trans-tetrahydro cannabinol; 11-acetoxy-(−)-Δ 9 -trans-tetrahydrocannabinolic acid A; 8-oxo-(−)-Δ 9 -trans-tetrahydrocannabinol; (−)-Δ 9 -trans-tetrahydrocannabiphorol; (−)-Δ 9 -trans-tetrahydrocannabihexol; cannabisol; cannabigerol; cannabigerolic acid; monomethyl ether of cannabigerol; monomethyl ether of cannabigerolic acid; Cannabigerovarin; cannabigerovarinic acid; cannabinerolic acid; 5-acetyl-4-hydroxy-cannabigerol; γ-eudesmyl-cannabigerolate; α-cadinyl-cannabigerolate; Cannabigerol; Cannabigerolic acid; (2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-3-methoxy-5-pentylphenol; Cannabigerolic acid monomethyl ether; Cannabigerovarin; 3-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-2,4-dihydroxy-6-propylbenzoic acid; 2-[(1R,6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; 2-[(1R,6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; Cannabidiol-3-monomethyl ether; (1R-trans)-5-butyl-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; 2-[(6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-propyl-1,3-benzenediol; 2,4-Dihydroxy-3-[(1R,6R)-6-isopropenyl-3-methyl-2-cyclohexen-1-yl]-6-propylbenzoic acid; 2-[(1R,6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-methyl-1,3-benzenediol; 5-hexyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; 5-Heptyl-2-[(1R,6R)-6-isopropenyl-3-methyl-2-cyclohexen-1-yl]-1,3-benzenediol; Cannabitwinol, and combinations thereof.
3 . The rehydrating cannabis solution of claim 1 further comprising a packet, the packet (a) contains the rehydrating cannabis solution, and (b) has an opening that permits the rehydrating cannabis solution to off-gas.
4 . The rehydrating cannabis solution of claim 1 further comprising a packet, the packet has a multi-cell absorbent material surrounded by a liquid impermeable, vapor permeable membrane, the multi-cell absorbent material contains the rehydrating cannabis solution, and the liquid impermeable, vapor permeable membrane has at least one opening that permits the rehydrating cannabis solution to off-gas.
5 . A closeable food-grade container comprising at least one wall that defines a chamber, the packet of claim 3 is positioned in the chamber.
6 . The closeable food-grade container of claim 3 wherein the packet has the rehydrating cannabis solution consisting of the modified cannabis hash oil
(a) derived from a cannabis hash oil extracted from a marijuana plant and the cannabis hash oil has (i) cannabis chemical compounds and (ii) over 5% of the cannabis chemical compounds are cannabinoid compounds;
(b) has the cannabis chemical compounds and
(c) has a percentage of cannabinoid compounds that ranges between 0.01% and up to 0.3%.
7 . The closeable food-grade container of claim 3 comprising a lid positioned over a chamber, wherein the packet is positioned in the lid.
8 . The rehydrating cannabis solution of claim 1 wherein the modified cannabis hash oil is not derived from a hemp plant.
9 . The rehydrating cannabis solution of claim 1 wherein the modified cannabis hash oil comprises natural terpenes and synthetic terpenes.
10 . The rehydrating cannabis solution of claim 1 wherein the modified cannabis hash oil comprises natural cannabinoid compounds and synthetic cannabinoid compounds.
11 . A rehydrating cannabis solution comprising a modified cannabis hash oil having
(a) 0.01% and up to 0.3% of cannabinoids selected from the group consisting of (−)-Δ 9 -trans-tetrahydrocannabinol; 8α-hydroxy-(−)-Δ 9 -trans-tetrahydrocannabinol; 8-oxo-(−)-Δ 9 -trans-tetrahydrocannabinol, (−)-Δ 9 -trans-tetrahydrocannabinolic acid B; (−)-Δ 9 -trans-tetrahydrocannabinolic acid A-C 4 ; 11-acetoxy-(−)-Δ 9 -trans-tetrahydrocannabinolic acid A and decarboxylized compounds thereof; (b) at least one phenol compound selected from the group consisting of phloroglucinol β-D-glucoside, vanillin, eugenol, iso-eugenol, trans-anethol, cis-anethol, methyleugenol, and combinations thereof; (c) at least one terpene compound selected from the group consisting of myrcene, cis-β-ocimene, trans-β-ocimene, p-cymene, p-cymenene, α-terpinene, β-phellandrene, γ-terpinene, α-terpinolene, α-phellandrene, (+)-Limonene, 3-phenyl-2-methyl-prop-1-ene, α-pinene, β-pinene, camphene, Δ 3 -carene, Δ 4 -carene, sabinene, α-thujene, linalool, citral B, nerol, geraniol, ipsdienol, citronellol, 2-methyl-2-heptene-6-one, geranyl acetone, m-mentha-1,8-(9)-dien-5-ol, carvacrol, carvone, α-terpineol, terpinene-4-ol, 3-terpinolenone, pulegone, dihydrocarvone, β-terpineol, dihydrocarveyl acetate, p-cymene-8-ol, cis-carveol, β-cyclocitral, safranal, linalool oxide, cis-linalool oxide, perillene, sabinol, thujyl alcohol, cis-sabinene hydrate, sabinene hydrate, 1,8-cineol, 1,4-cineol, piperitone oxide, piperitenone oxide, fenchyl alcohol, fenchone, borneol, bornyl acetate, camphor, camphene hydrate, α-pinene oxide, pinocarveol, pinocarvone, α-caryophyllene, β-caryophyllene, caryophyllene oxide, curcumene, α-trans-bergamotene, α-selinene, β-farnesene, longifolene, humulene epoxide I, humulene epoxide II, caryophyllene alcohol, β-bisabolene, allo-aromadendrene, calamenene, and α-copaene, nerolidol, α-gurjunene, iso-caryophyllene, β-selinene, selina-3,7 (11)-diene, selina-4(14), 7 (11)-diene, α-bisabolol, α-cedrene, α-cubebene, δ-cadinene, epi-β-santalene, farnesol, γ-cadinene, γ-elemene, γ-eudesmol, guaiol, ledol, trans-trans-α-farnesene, (Z)-β-farnesene, farnesyl acetone, α-cadinene, α-cis-bergamotene, α-eudesmol, α-guaiene, α-longipinene, α-ylangene, β-elemene, β-eudesmol, epi-α-bisabolol, γ-cis-bisabolene, γ-curcumene, γ-muurolene, γ-trans-bisabolene, viridiflorene, germacrene-B, clovandiol, phytol, neophytadiene, friedelan-3-one, epifriedelanol, vomifoliol, dihydrovomifoliol, β-ionone, dihydroactinidiolide, cannabisativine, anhydrocannabisativine, and combinations thereof.
12 . The rehydrating cannabis solution of claim 11 wherein modified cannabis hash oil has the percentage of cannabinoid compounds ranging between 0.1% and up to 0.3% by extracting the tetrahydrocannabinol compounds from the cannabis hash oil; the extracted tetrahydrocannabinol compounds are selected from the group consisting of at least one of the following tetrahydrocannabinol compounds: (−)-Δ 9 -trans-tetrahydrocannabinol; (−)-Δ 9 -trans-tetrahydrocannabinolic acid A; (−)-Δ 9 -trans-tetrahydrocannabinolic acid B; (−)-Δ 9 -trans-tetrahydrocannabiorcol; (−)-Δ 9 -trans-tetrahydrocannabinal; (−)-Δ 9 -trans-tetrahydrocannabivarinic acid; (−)-Δ 9 -trans-tetrahydrocannabinol-C 4 ; (−)-Δ 9 -trans-tetrahydrocannabinolic acid A-C 4 ; (−)-Δ 9 -trans-tetrahydrocannabivarin; β-fenchyl (−)-d-9-trans-tetrahydrocannabinolate; (−)-Δ 9 -trans-tetrahydrocannabiorcolic acid; α-fenchyl (−)-Δ 9 -trans-tetrahydrocannabinolate; epi-bornyl (−)-Δ 9 -trans-tetrahydrocannabinolate; bornyl (−)-Δ 9 -trans-tetrahydrocannabinolate; α-terpenyl (−)-Δ 9 -trans-tetrahydrocannabinolate; 4-terpenyl (−)-Δ 9 -trans-tetrahydrocannabinolate; α-cadinyl (−)-Δ 9 -trans-tetrahydrocannabinolate; γ-eudesmyl (−)-Δ 9 -trans-tetrahydrocannabinolate; 8α-hydroxy-(−)-Δ 9 -trans-tetrahydrocannabinol; 8β-hydroxy-(−)-Δ 9 -trans-tetrahydro cannabinol; 11-acetoxy-(−)-Δ 9 -trans-tetrahydrocannabinolic acid A; 8-oxo-(−)-Δ 9 -trans-tetrahydrocannabinol; (−)-Δ 9 -trans-tetrahydrocannabiphorol; (−)-Δ 9 -trans-tetrahydrocannabihexol; cannabisol; cannabigerol; cannabigerolic acid; monomethyl ether of cannabigerol; monomethyl ether of cannabigerolic acid; Cannabigerovarin; cannabigerovarinic acid; cannabinerolic acid; 5-acetyl-4-hydroxy-cannabigerol; Y-eudesmyl-cannabigerolate; α-cadinyl-cannabigerolate; Cannabigerol; Cannabigerolic acid; (2-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-3-methoxy-5-pentylphenol; Cannabigerolic acid monomethyl ether; Cannabigerovarin; 3-[(2E)-3,7-Dimethyl-2,6-octadien-1-yl]-2,4-dihydroxy-6-propylbenzoic acid; 2-[(1R,6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; 2-[(1R,6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol; Cannabidiol-3-monomethyl ether; (1R-trans)-5-butyl-2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; 2-[(6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-propyl-1,3-benzenediol; 2,4-Dihydroxy-3-[(1R,6R)-6-isopropenyl-3-methyl-2-cyclohexen-1-yl]-6-propylbenzoic acid; 2-[(1R,6R)-6-Isopropenyl-3-methyl-2-cyclohexen-1-yl]-5-methyl-1,3-benzenediol; 5-hexyl-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-1,3-benzenediol; 5-Heptyl-2-[(1R,6R)-6-isopropenyl-3-methyl-2-cyclohexen-1-yl]-1,3-benzenediol; Cannabitwinol, and combinations thereof.
13 . The rehydrating cannabis solution of claim 11 further comprising a packet, the packet (a) contains the rehydrating cannabis solution, and (b) has an opening that permits the rehydrating cannabis solution to off-gas.
14 . The rehydrating cannabis solution of claim 11 further comprising a packet, the packet has a multi-cell absorbent material surrounded by a liquid impermeable, vapor permeable membrane, the multi-cell absorbent material contains the rehydrating cannabis solution, and the liquid impermeable, vapor permeable membrane has at least one opening that permits the rehydrating cannabis solution to off-gas.
15 . A closeable food-grade container comprising at least one wall that defines a chamber, the packet of claim 13 is positioned in the chamber.
16 . The closeable food-grade container of claim 13 wherein the packet has the rehydrating cannabis solution consisting of the modified cannabis hash oil
(a) derived from a cannabis hash oil extracted from a marijuana plant and the cannabis hash oil has (i) cannabis chemical compounds and (ii) over 10% of the cannabis chemical compounds are cannabinoid compounds;
(b) has the cannabis chemical compounds and
(c) has a percentage of cannabinoid compounds that ranges between 0.01% and up to 0.3%.
17 . The closeable food-grade container of claim 13 comprising a lid positioned over a chamber, wherein the packet is positioned in the lid.
18 . The rehydrating cannabis solution of claim 11 wherein the modified cannabis hash oil is not derived from a hemp plant.
19 . The rehydrating cannabis solution of claim 11 wherein the modified cannabis hash oil comprises natural terpenes and synthetic terpenes.
20 . The rehydrating cannabis solution of claim 11 wherein the modified cannabis hash oil comprises natural cannabinoid compounds and synthetic cannabinoid compounds.Join the waitlist — get patent alerts
Track US2025113855A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.